241.36  -5.13 (-2.08%)		10-16 16:00
Open: 246.405 High: 246.805 Volume: 14,476		Pre. Close: 246.49 Low: 239.945 Market Cap: 487(M)

Short term
Mid term
Targets	6-month :	289.54	1-year :	338.19
Resists	First :	247.89	Second :	289.54
Pivot price	240.33
Supports	First :	236.44	Second :	229.36
MAs	MA(5) :	240.81	MA(20) :	240.7
	MA(100) :	217.18	MA(250) :	200.44
MACD	MACD :	1.7	Signal :	1.9
%K %D	K(14,3) :	73.7	D(3) :	63.3
RSI	RSI(14): 53.5
52-week	High :	247.89	Low :	175.42

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BBH ] has closed below upper band by 43.1%. Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	247.07 - 248.49	248.49 - 249.77
Low:	236.71 - 238.24	238.24 - 239.63
Close:	239.16 - 241.61	241.61 - 243.83

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.

Sat, 10 Oct 2026
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH - The Motley Fool

Sat, 10 Oct 2026
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH - The Globe and Mail

Sat, 10 Oct 2026
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Motley Fool

Sat, 10 Oct 2026
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Globe and Mail

Thu, 24 Sep 2026
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Motley Fool

Wed, 16 Sep 2026
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.